FDA.reportPublic FDA data

LIFITEGRAST Pharmacologic Class Indexing

Class set ID
9e96e8de-d095-4a96-8cc1-d9db28708a4e
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016Novartis Pharmaceuticals Corporation | The Ritedose Corporation202508186
These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016Bausch & Lomb Incorporated | The Ritedose Corporation202411215
These highlights do not include all the information needed to use LIFITEGRAST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LIFITEGRAST OPHTHALMIC SOLUTION. LIFITEGRAST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2016Aurobindo Pharma Limited | Eugia Pharma Specialities Limited202311131